Daniel J Indelicato Selected Research

Craniopharyngioma (Craniopharyngiomas)

7/2022	Spinal ectopic recurrence of craniopharyngioma in a pediatric patient.
5/2022	Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series.
1/2022	Pre- and Posttherapy Risk Factors for Vasculopathy in Pediatric Patients With Craniopharyngioma Treated With Surgery and Proton Radiation Therapy.
4/2021	Correction to: Clinical outcomes following proton therapy for adult craniopharyngioma: a single‑institution cohort study.
2/2021	Variation in relative biological effectiveness for cognitive structures in proton therapy of pediatric brain tumors.
1/2021	Diffusion Tensor Imaging-Based Analysis of Baseline Neurocognitive Function and Posttreatment White Matter Changes in Pediatric Patients With Craniopharyngioma Treated With Surgery and Proton Therapy.
1/2021	Response to: 'Comments on "Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma" by Toussaint, et al.: Prior similar field arrangement work and a need for variable RBE Use'.
1/2021	Spatial Agreement of Brainstem Dose Distributions Depending on Biological Model in Proton Therapy for Pediatric Brain Tumors.
1/2020	Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma.
1/2020	Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel J Indelicato Research Topics

Disease

62	Neoplasms (Cancer) 05/2022 - 12/2006
18	Craniopharyngioma (Craniopharyngiomas) 07/2022 - 04/2013
15	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 01/2009
10	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 02/2008
9	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2013
8	Ependymoma 01/2022 - 08/2012
8	Rhabdomyosarcoma 10/2021 - 02/2012
6	Medulloblastoma 01/2022 - 09/2014
5	Glioma (Gliomas) 01/2021 - 04/2013
4	Breast Neoplasms (Breast Cancer) 02/2021 - 03/2007
4	Aggressive Fibromatosis (Desmoid) 01/2021 - 09/2011
4	Chordoma 01/2021 - 05/2016
4	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2008
3	Chondrosarcoma 01/2021 - 05/2016
3	Second Primary Neoplasms (Neoplasms, Second) 01/2021 - 01/2016
3	Meningioma (Meningiomas) 12/2016 - 01/2011
2	Necrosis 03/2021 - 01/2019
2	Infections 01/2021 - 02/2012
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 05/2015
2	Cysts 01/2020 - 09/2015
2	Pinealoma (Pineoblastoma) 01/2020 - 01/2020
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 12/2019
2	Sensorineural Hearing Loss 12/2019 - 09/2018
2	Cataract (Cataracts) 12/2019 - 01/2018
2	Nasopharyngeal Carcinoma 12/2019 - 12/2016
2	Mucositis 12/2019 - 05/2019
2	Neutropenia 01/2018 - 02/2012
2	Central Nervous System Neoplasms 12/2017 - 01/2010
2	Leukemia 06/2012 - 01/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2011 - 08/2009
2	Prostatic Neoplasms (Prostate Cancer) 09/2009 - 08/2009
1	Multiple Sclerosis 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Radiation Pneumonitis 11/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Otitis Media 01/2021
1	Choroid Plexus Carcinoma 01/2021
1	Bilateral Hearing Loss 01/2021
1	Alveolar Rhabdomyosarcoma 01/2020
1	Nocturnal Enuresis (Bedwetting) 01/2020
1	Optic Nerve Diseases (Optic Neuropathy) 01/2020
1	Conductive Hearing Loss 01/2020
1	Esophageal Stenosis (Esophageal Stricture) 12/2019
1	Hypothyroidism 12/2019
1	AIDS-Related Complex (ARC) 10/2019
1	Ototoxicity 10/2019
1	Vision Disorders (Hemeralopia) 10/2019
1	Xerostomia 10/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2019
1	Pain (Aches) 05/2019
1	Vomiting 01/2019
1	Nausea 01/2019
1	Heart Failure 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Epilepsy (Aura) 01/2019
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018
1	Stroke (Strokes) 01/2018

Drug/Important Bio-Agent (IBA)

15	Protons (Proton)IBA 01/2022 - 01/2010
4	Biological ProductsIBA 02/2021 - 01/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 02/2012
3	Hormones (Hormone)IBA 01/2021 - 01/2018
2	Vincristine (Oncovin)FDA LinkGeneric 12/2021 - 02/2012
2	Phosphotransferases (Kinase)IBA 05/2015 - 01/2011
2	Dihydrotachysterol (AT 10)IBA 02/2013 - 06/2012
1	Pharmaceutical PreparationsIBA 12/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2021
1	tyrosyltyrosine (Tyr-Tyr)IBA 01/2021
1	Brachyury protein (Brachyury)IBA 01/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	VenomsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	IceIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 11/2019
1	temsirolimus FDA Link 11/2019
1	Growth Hormone (Somatotropin)IBA 10/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	AnthracyclinesIBA 01/2019
1	Ondansetron (Zofran)FDA LinkGeneric 01/2019

Therapy/Procedure

73	Radiotherapy 07/2022 - 12/2006
51	Proton Therapy 01/2022 - 09/2009
22	Therapeutics 01/2022 - 12/2006
15	Drug Therapy (Chemotherapy) 12/2021 - 11/2008
6	Aftercare (After-Treatment) 01/2018 - 02/2008
3	Craniospinal Irradiation 01/2022 - 01/2020
3	Induction Chemotherapy 01/2021 - 12/2019
3	Salvage Therapy 11/2020 - 01/2009
3	Combined Modality Therapy 03/2012 - 03/2007
2	Re-Irradiation 03/2021 - 01/2009
2	Enteral Nutrition (Feeding, Tube) 12/2019 - 05/2019
2	Treatment Delay 01/2018 - 01/2018
2	Segmental Mastectomy (Lumpectomy) 10/2009 - 07/2009
1	Reoperation 01/2021
1	Hearing Aids (Hearing Aid) 01/2021
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020
1	Cystectomy 01/2020
1	Total Parenteral Nutrition 12/2019
1	Physical Therapy Modalities (Physical Therapy Technique) 10/2019
1	Operative Surgical Procedures 01/2018